This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Google Scholar Articles by DeSesso, J M Articles by Watson, R E Search for Related Content PubMed PubMed Citation Articles by DeSesso, J M Articles by Watson, R E Social Bookmarking                   What's this?

The case for integrating low dose, beneficial responses into US EPA risk assessments

Mitretek Systems, 3150 Fairview Park Drive, Falls Church, VA 22042, USA jdesesso{at}mitretek.org

R E Watson

Mitretek Systems, 3150 Fairview Park Drive, Falls Church, VA 22042, USA

When conducting risk assessments, the US Environmental Protection Agency (EPA) does not currently consider the beneficial effects from exposure to concentrations of agents below the no observed adverse effect level (NOAEL). If such benefits were observed, and if the beneficial and toxicological mechanisms of action were identical, this would probably be represented as a ‘j–shaped’ hormetic dose–response curve. If such data are available, they should be considered when assigning uncertainty factors for safe exposure calculations. However, when such data are not readily available, as is likely the case when the mechanism of action of the benefit differs from that of toxicity, current US EPA methods appear adequate.

Key Words: beneficial effects • dose–response • low–dose • risk assessment

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?